International Symposium on Multisystem Inflammatory Disorders
May, 24-26, 2019 Lübeck, Germany
Disclosure of cooperation
In accordance with transparency obligations, we transparently present the services and the extent of support provided by companies to participants both in announcing and holding the congress.
Disclosure of payments made for the Symposium
| Institution | Sponsoring | Service |
Actelion Pharmaceuticals Deutschland GmbH | 5.000 € | Industrial exhibition, Marketing |
Boehringer Ingelheim Pharma GmbH & Co. KG | 3.000 € | Industrial exhibition, Marketing |
BMS Bristol-Myers Squibb GmbH & Co. KGaA | 2.000 € | Industrial exhibition, Marketing |
CHUGAI PHARMA GERMANY GMBH | 2.000 € | Industrial exhibition, Marketing |
Lilly Deutschland GmbH | 2.000 € | Industrial exhibition, Marketing |
MSD Sharp & Dohme GmbH | 2.000 € | Industrial exhibition, Marketing |
Sanofi-Aventis Deutschland GmbH | 2.000 € | Industrial exhibition, Marketing |
Pfizer Pharma GmbH | 1.800 € | Industrial exhibition, Marketing |
GSK GlaxoSmithKline GmbH & Co. KG | 1.500 € | Industrial exhibition, Marketing |
Novartis Pharma GmbH | 1.500 € | Industrial exhibition, Marketing |
EUROIMMUN AG a PerkinElmer Company | 1.300 € | Industrial exhibition, Marketing |
Celgene GmbH | 1.200 € | Industrial exhibition, Marketing |
AbbVie Deutschland GmbH & Co. KG | 1.000 € | Industrial exhibition, Marketing |
Bayer Vital GmbH | 1.000 € | Industrial exhibition, Marketing |
Biogen GmbH | 1.000 € | Industrial exhibition, Marketing |
Janssen-Cilag GmbH | 1.000 € | Industrial exhibition, Marketing |
Sandoz Hexal AG | 1.000 € | Industrial exhibition, Marketing |
Shire Deutschland GmbH | 1.000 € | Industrial exhibition, Marketing |
UCB Pharma GmbH | 1.000 € | Industrial exhibition, Marketing |
Vifor Pharma Group | 1.000 € | Industrial exhibition, Marketing |
Swedish Orphan Biovitrum GmbH | 750 € | Marketing |